$QTTB

Mizuho Securities Raises Q32 Bio Price Target to $36 From $14, Outperform Rating Kept

Mizuho Securities Raises Q32 Bio Price Target to $36 From $14, Outperform Rating Kept

Top Midday Gainers

Twin Vee PowerCats (VEEE) has entered into a definitive agreement to merge with a subsidiary of US-based mineral exploration firm USFM and to privatize its marine business under the brands Twin Vee and Bahama Boat Works, the company said Monday.Shares of Twin Vee catapulted 478% as intraday trading volume soared to over 61.3 million from a daily average of about 215,000.Q32 Bio (QTTB) said Monday its treatment bempikibart achieved a 35.3% mean decrease in scalp hair loss severity from baseline measurements after 36 weeks in part B of a phase 2a clinical trial in patients with severe or very severe alopecia areata.Shares surged 87% amid a jump in intraday trading volume to over 24.1 million from a daily average of roughly 808,000.Braiin (BRAI) shares jumped 49% after the company said on Monday it launched Agentic Real Estate Intelligence and Automation, an artificial intelligence-related workforce designed specifically for the global real estate industry.More than 7.9 million shares of the company traded intraday compared with a daily average of about 256,000.Price: $27.86, Change: $+23.04, Percent Change: +478.01%

Top Midday Gainers

Astrotech (ASTC) shares soared 511% amid heavy trading after the company's board approved an initiative aimed at evaluating emerging opportunities associated with Moon-based quantum computing manufacturing.More than 113.6 million shares of the company traded intraday compared with a daily average of about 2.12 million.Q32 Bio (QTTB) said Wednesday it agreed to raise about $55 million through a private placement with institutional and accredited investors.Shares soared 70% amid a surge in intraday trading volume to over 18.0 million from a daily average of roughly 322,000.Dycom Industries (DY) reported fiscal Q1 adjusted net income and contract revenue above market expectations on Wednesday. It also increased the fiscal 2027 guidance for contract sales, beating consensus.Shares advanced 31% as intraday trading volume rose to over 861,000 from a daily average of about 439,000.Price: $547.30, Change: $+126.83, Percent Change: +30.16%

Mizuho Initiates Q32 Bio at Outperform With $14 Price Target

Q32 Bio (QTTB) has an average rating of buy and mean price target of $14.25, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)

Cantor Fitzgerald Initiates Q32 Bio at Overweight